1
- --------------------- ---------------------------
[LOGO] INAMED CORPORATION
5540 Ekwill Street, Suite D
Santa Barbara, CA 93111
(805) 692-5400 Telephone
News Release (805) 692-5432 Facsimile
for immediate release
INAMED PROVIDES MID-QUARTER SALES UPDATE
--------------------------------------------------
SANTA BARBARA, CA, May 22, 2001 - Inamed Corporation (NASDAQ: IMDC) today
provided investors with a mid-quarter sales update for the second quarter ending
June 30, 2001. Sales through mid May 2001 were $31.3 million, down 4.5% from the
prior year. On a year-to-date basis, sales were $89.1 million, 4.2% below the
same period last year.
Commenting on the mid-quarter results, Richard G. Babbitt, Inamed's chairman and
chief executive officer, said, "As in the first quarter, U.S. breast implant
dollar sales are down, while unit sales are up, again due to a shift in mix.
Outside the U.S., particularly in Europe, collagen sales continue to run behind
the prior year, in part due to concerns relating to BSE. However, our obesity
products again showed very strong sales in the first half of the second quarter,
consistent with the prior quarter. We look forward to adding to our obesity
product sales, as we continue to expect FDA approval for the Lap-Band before the
close of the second quarter. We remain confident of our excellent long-term
growth prospects."
ABOUT INAMED CORPORATION
Inamed is a global surgical and medical device company engaged in the
development, manufacturing and marketing of products for the plastic and
reconstructive surgery, aesthetic medicine and obesity markets. Inamed sells a
variety of lifestyle products used to make people look younger and more
attractive, including breast implants for cosmetic augmentation and
collagen-based facial implants to correct facial wrinkles and to improve lip
definition. Inamed also sells products which address women's health issues,
including breast implants for reconstructive surgery following a mastectomy, and
devices which treat severe obesity and urinary incontinence.
-more-
2
FORWARD LOOKING STATEMENTS
This release contains, in addition to historical information, forward-looking
statements. Such statements are based on management's current expectations and
are subject to a number of uncertainties and risks that could cause actual
results to differ materially from those described in the forward-looking
statements. Factors that may cause such a difference include, but are not
limited to, those described in the Company's annual report on Form 10-K for the
year ended December 31, 2000.
MEDIA CONTACT: INVESTOR CONTACT:
Denise DesChenes/Anna Cordasco Michael Doty, SVP & CFO
Citigate Sard Verbinnen Inamed Corporation
212-687-8080 212-273-3430
###